Class Action Lawsuit Filed Against Regencell Bioscience Holdings Limited
A class action lawsuit has been filed in the United States District Court for the District of Maryland against Regencell Bioscience Holdings Limited (ticker: not provided). The suit alleges that company officials made materially false or misleading statements, exposing investors to financial risk and regulatory scrutiny. Shareholders who purchased securities between October 28, 2024, and October 31, 2025 are eligible.
Topics: market manipulation securities fraud shareholder litigation